Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Chongqing Peg-Bio Biopharm Co., Ltd.
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Boston Children's Hospital
Center for International Blood and Marrow Transplant Research
Centre Henri Becquerel
Murdoch Childrens Research Institute
Fayoum University
Thomas Jefferson University
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
University Hospital, Grenoble
Duke University
Beijing Suncadia Pharmaceuticals Co., Ltd
Fadoi Foundation, Italy
Thomas Jefferson University
Rigshospitalet, Denmark
University of Aberdeen
Fred Hutchinson Cancer Center
University of Utah
LEO Pharma
Centre Hospitalier Annecy Genevois
AstraZeneca
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University Hospital, Angers
Radboud University Medical Center
Radboud University Medical Center
Advice Pharma Group srl
Centre Leon Berard
Assistance Publique - Hôpitaux de Paris
Ottawa Hospital Research Institute
Duke University
National Cancer Institute (NCI)
Radboud University Medical Center
National Cancer Institute (NCI)
King's College Hospital NHS Trust
AstraZeneca
Memorial Sloan Kettering Cancer Center
Swiss Federal Institute of Technology
AstraZeneca
Ohio State University Comprehensive Cancer Center
Virginia Commonwealth University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Alliance Foundation Trials, LLC.
Sobi, Inc.
M.D. Anderson Cancer Center